Company Filing History:
Years Active: 2022-2024
Title: Rujian Ma: Innovator in Pharmaceutical Synthesis
Introduction
Rujian Ma is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical synthesis, holding a total of 2 patents. His work focuses on innovative processes that enhance the efficiency and effectiveness of drug development.
Latest Patents
Rujian Ma's latest patents include a process for the synthesis of 6-((3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl)-3-(tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one. This patent relates to processes for preparing 6-((3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl)-3-(tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one. Another significant patent involves a similar synthesis process, emphasizing the use of the chiral acid (+)-O,O-Dibenzoyl-D-tartaric acid.
Career Highlights
Throughout his career, Rujian Ma has worked with prominent companies in the pharmaceutical industry, including Imara Inc. and Cardurion Pharmaceuticals, LLC. His expertise in synthesis processes has positioned him as a valuable asset in these organizations.
Collaborations
Rujian Ma has collaborated with notable professionals in his field, including Niels Svenstrup and Jun Zhang. These partnerships have contributed to the advancement of his research and innovations.
Conclusion
Rujian Ma's contributions to pharmaceutical synthesis through his patents and collaborations highlight his role as an influential inventor in the industry. His work continues to impact the development of new therapeutic solutions.